140 related articles for article (PubMed ID: 31868861)
1. Enzyme replacement therapy in Fabry disease in Poland: a position statement.
Nowicki M; Bazan-Socha S; Błażejewska-Hyzorek B; Gellert R; Imiela J; Kaźmierczak J; Kłopotowski M; Oko-Sarnowska Z; Pawlaczyk K; Ponikowski P; Sławek J; Sykut-Cegielska J; Witkowski A; Zwolińska D
Pol Arch Intern Med; 2020 Jan; 130(1):91-97. PubMed ID: 31868861
[No Abstract] [Full Text] [Related]
2. Successful long-term enzyme replacement therapy in a young adult with Fabry disease.
Kampmann C; Kalkum G; Beck M; Whybra C
Clin Genet; 2013 Apr; 83(4):395-6. PubMed ID: 22881192
[No Abstract] [Full Text] [Related]
3. Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.
Martin-Suárez I; Suárez-Marrero C
Int J Clin Pract; 2010 Jun; 64(7):995. PubMed ID: 20584233
[No Abstract] [Full Text] [Related]
4. Fabry disease: is there a role for enzyme replacement therapy?
Mehta AB
J Intern Med; 2013 Oct; 274(4):329-30. PubMed ID: 23662843
[No Abstract] [Full Text] [Related]
5. Enzyme replacement therapy for Fabry's disease.
Waldek S; Germain DP; Wanner C; Warnock DG
Lancet; 2010 May; 375(9725):1523; author reply 1523-4. PubMed ID: 20435225
[No Abstract] [Full Text] [Related]
6. Enzyme replacement therapy for Fabry's disease.
Deegan P
Lancet; 2010 May; 375(9725):1522-3; author reply 1523-4. PubMed ID: 20435224
[No Abstract] [Full Text] [Related]
7. Fabry disease: dose matters.
Warnock DG; Mauer M
J Am Soc Nephrol; 2014 Apr; 25(4):653-5. PubMed ID: 24556355
[No Abstract] [Full Text] [Related]
8. Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.
Lenders M; Brand E
J Am Soc Nephrol; 2018 Sep; 29(9):2265-2278. PubMed ID: 30093456
[No Abstract] [Full Text] [Related]
9. [Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].
Lidove O; Choukroun G; Bekri S; Viot G; Tsimaratos M; Joly D
Presse Med; 2010 May; 39(5):527-9. PubMed ID: 20194001
[No Abstract] [Full Text] [Related]
10. Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion.
Lenders M; Schmitz B; Brand SM; Foell D; Brand E
J Allergy Clin Immunol; 2018 Jun; 141(6):2289-2292.e7. PubMed ID: 29421273
[No Abstract] [Full Text] [Related]
11. Prominent regression of corneal deposits in Fabry disease 16 years after initiation of enzyme replacement therapy.
Koh S; Sakai N; Maeda N; Nishida K
Acta Ophthalmol; 2018 Mar; 96(2):e255-e256. PubMed ID: 28834375
[No Abstract] [Full Text] [Related]
12. Two successful pregnancies in a woman with Fabry continuing enzyme replacement therapy.
Paydas S; Akcabay C
Ther Apher Dial; 2024 Apr; 28(2):329-330. PubMed ID: 37941141
[No Abstract] [Full Text] [Related]
13. Treatment with agalsidase beta during pregnancy in Fabry disease.
Politei JM
J Obstet Gynaecol Res; 2010 Apr; 36(2):428-9. PubMed ID: 20492401
[TBL] [Abstract][Full Text] [Related]
14. Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease.
Senocak Tasci E; Bicik Z
Iran J Kidney Dis; 2015 Sep; 9(5):406-8. PubMed ID: 26338166
[TBL] [Abstract][Full Text] [Related]
15. Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?
Fauchais AL; Prey S; Ouatara B; Vidal E; Sparsa A
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):737-8. PubMed ID: 19925601
[No Abstract] [Full Text] [Related]
16. Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.
Cybulla M; Kurschat C; West M; Nicholls K; Torras J; Sunder-Plassmann G; Feriozzi S
J Nephrol; 2013; 26(4):645-51. PubMed ID: 23023720
[TBL] [Abstract][Full Text] [Related]
17. [Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature].
Riccio E; Capuano I; Visciano B; Marchetiello C; Petrillo F; Pisani A
G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402625
[TBL] [Abstract][Full Text] [Related]
18. Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease.
Oder D; Nordbeck P; Wanner C
Nephron; 2016; 134(1):30-6. PubMed ID: 27576727
[TBL] [Abstract][Full Text] [Related]
19. [Utility of enzyme replacement therapy in Fabry disease].
Politei JM; Dubrovsky A
Med Clin (Barc); 2010 Apr; 134(9):402-5. PubMed ID: 20138313
[TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement therapy for Fabry disease: proving the clinical benefit.
Breunig F; Wanner C
Nephrol Dial Transplant; 2003 Jan; 18(1):7-9. PubMed ID: 12480950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
